25
Participants
Start Date
August 31, 2011
Primary Completion Date
March 31, 2013
Study Completion Date
August 31, 2013
DNA HIVIS and MVA-CMDR
600 µg i.d. (separate plasmids pools) of DNA priming at weeks 0, 4 and 12; 108 pfu i.m. MVA boosting at weeks 24 and 36
DNA HIVIS and MVA-CMDR
1200 µg i.d. (separate plasmids pools) of DNA priming at weeks 0, 4 and 12 ; 108 pfu i.m. MVA boosting at weeks 24 and 36
Saline solution
2 x 0.1 ml of saline solution i.d at weeks 0, 4 and 12 ; saline solution i.m at weeks 24 and 36
Saline solution
2 x 0.2 ml of saline solution i.d at weeks 0, 4 and 12 ; saline solution i.m at weeks 24 and 36
Centro de Investigação e Treino em Saúde de Polana Caniço, Maputo
Swedish Institute for Communicable Disease Control, Sweden
UNKNOWN
European and Developing Countries Clinical Trials Partnership (EDCTP)
OTHER_GOV
Instituto Nacional de Saúde, Mozambique
OTHER_GOV